Provider Select Awards QUIDEL Contract For Rapid Diagnostic
Tests For Physicians' Offices
Maybe this will finally get this stock moving!!!!
SAN DIEGO, Feb. 3 /PRNewswire/ -- QUIDEL Corporation (Nasdaq: QDEL - news) has signed a five-year
agreement with Provider Select(TM) to become its sole source supplier of rapid diagnostic testing products to
Provider Select affiliated physicians' offices and other non-acute care sites.
The contract covers all of QUIDEL's professional-use rapid testing products including pregnancy tests,
ovulation predictors and infectious disease tests for Strep A, H. pylori, Chlamydia, and Mononucleosis.
''We are pleased to have been chosen as the provider of rapid diagnostic testing products for physician's
offices affiliated with Premier's Provider Select and look forward to a long-term relationship,'' said Steven T.
Frankel, President and Chief Executive Officer of QUIDEL. ''This contract is another important achievement for
our company, and we believe it will provide a cost and quality advantage to physicians that are affiliated with
Provider Select. It validates our strategic plan to expand distribution into evolving healthcare markets.''
Provider Select, Inc. a Premier affiliate corporation, was established in 1997 to respond to the unique needs of
non-acute care providers. Provider Select programs are aimed not only at assisting members in acquiring the
highest quality medical and non-medical supplies and equipment at best prices, but also at addressing other
areas of non-acute operating expenses in the future.
Premier, Inc. is a strategic alliance of leading hospitals and healthcare systems across the country,
representing 230 owners and the 800 hospitals and healthcare facilities they operate, and approximately 900
other affiliated hospital and healthcare organizations. Premier maintains major offices in Charlotte, NC,
Chicago, IL, San Diego, CA and Washington, D.C.
Group purchasing of supplies, pharmaceuticals and equipment is one of the major programs Premier operates
to support its owners' and affiliates' efforts to hold down healthcare costs, improve quality and stay ahead of
advances in clinical knowledge, technology and market changes such as managed care. Premier's current
purchasing volume of goods and services for its organizations is approximately $8 billion annually.
QUIDEL Corporation discovers, develops, manufactures and markets rapid immunodiagnostic products for
point-of-care detection of human medical conditions and illnesses. These products provide simple, accurate
and cost- effective diagnoses for acute and chronic conditions in the areas of reproductive and women's health,
infectious diseases, allergies and autoimmune disorders. QUIDEL's products are sold to professionals in the
physician's office and clinical laboratory, and to consumers through retail drug stores. QUIDEL is based in San
Diego. |
